Literature DB >> 7149969

Effects of testosterone replacement on sexual behavior in hypogonadal men.

P Salmimies, G Kockott, K M Pirke, H J Vogt, W B Schill.   

Abstract

Fifteen patients with hypogonadism due to testicular, pituitary, or hypothalamic failure were studied. After a pretreatment period without substitution, patients received intramuscular injections of testosterone enanthate, equivalent to 25, 50, 100, and 250 mg testosterone, or placebo. Each dose was given for 4 weeks, with injections given every 2 weeks. All patients with plasma testosterone values below 2 ng/ml during the pretreatment period reported impaired sexual function. They responded to testosterone injections (50, 100, and 250 mg) with improvement of sexual behavior, as rated by sexual desire and frequency of erections and ejaculations. In the range between 2.0 and 4.5 ng testosterone per ml, four patients reported high frequencies of erections and ejaculations that did not change after testosterone treatment. Four other patients with testosterone values in the same range reported impaired sexual behavior and were successfully treated with testosterone enanthate. These data indicate that male sexual behavior is testosterone dependent and that the individual limit of plasma testosterone below which sexual behavior is impaired lies between 2.0 and 4.5 ng/ml.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7149969     DOI: 10.1007/bf01541595

Source DB:  PubMed          Journal:  Arch Sex Behav        ISSN: 0004-0002


  4 in total

1.  A comparison of three methods of measuring testosterone in plasma: competitive protein binding, radioimmunoassay without chromatography and radioimmunoassay including thin layer chromatography.

Authors:  K M Pirke
Journal:  Acta Endocrinol (Copenh)       Date:  1973-09

2.  Age related changes and interrelationships between plasma testosterone, oestradiol and testosterone-binding globulin in normal adult males.

Authors:  K M Pirke; P Doerr
Journal:  Acta Endocrinol (Copenh)       Date:  1973-12

3.  Radioimmunoassay for luteinizing hormone in human plasma or serum: physiological studies.

Authors:  W D Odell; G T Ross; P L Rayford
Journal:  J Clin Invest       Date:  1967-02       Impact factor: 14.808

4.  Effects of androgen on sexual behavior in hypogonadal men.

Authors:  J M Davidson; C A Camargo; E R Smith
Journal:  J Clin Endocrinol Metab       Date:  1979-06       Impact factor: 5.958

  4 in total
  14 in total

1.  Volume change of the prostate and seminal vesicles in male hypogonadism after androgen replacement therapy.

Authors:  I Sasagawa; T Nakada; T Kazama; S Satomi; T Terada; T Katayama
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

2.  Isolated hypogonadotropic hypogonadism in male identical twins.

Authors:  F Geola; J M Hershman
Journal:  West J Med       Date:  1989-01

3.  Relationship between testosterone and erectile dysfunction.

Authors:  J Rajfer
Journal:  Rev Urol       Date:  2000

Review 4.  Psychological and behavioural effects of endogenous testosterone levels and anabolic-androgenic steroids among males. A review.

Authors:  M S Bahrke; C E Yesalis; J E Wright
Journal:  Sports Med       Date:  1990-11       Impact factor: 11.136

5.  Treatment of depression in HIV+men: Literature review and report of an ongoing study of testosterone replacement therapy.

Authors:  J G Rabkin; G Wagner; R Rabkin
Journal:  Ann Behav Med       Date:  1996-03

6.  Effects of androgen treatment in impotent men with normal and low levels of free testosterone.

Authors:  C Carani; D Zini; A Baldini; L Della Casa; A Ghizzani; P Marrama
Journal:  Arch Sex Behav       Date:  1990-06

Review 7.  Testosterone therapy in men: clinical and pharmacological perspectives.

Authors:  A Gambineri; R Pasquali
Journal:  J Endocrinol Invest       Date:  2000-03       Impact factor: 4.256

Review 8.  Risks versus benefits of testosterone therapy in elderly men.

Authors:  S Basaria; A S Dobs
Journal:  Drugs Aging       Date:  1999-08       Impact factor: 3.923

9.  Sexuality changes in prostate cancer patients receiving antihormonal therapy combining the antiandrogen flutamide with medical (LHRH agonist) or surgical castration.

Authors:  L Rousseau; A Dupont; F Labrie; M Couture
Journal:  Arch Sex Behav       Date:  1988-02

10.  Increased sexual desire with exogenous testosterone administration in men with obstructive sleep apnea: a randomized placebo-controlled study.

Authors:  K L Melehan; C M Hoyos; B J Yee; K K Wong; P R Buchanan; R R Grunstein; P Y Liu
Journal:  Andrology       Date:  2015-11-26       Impact factor: 3.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.